Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Pulled Back, But Coronavirus Did Not

While viruses are counted among the simplest forms of life, they have quite a bearing on its advanced forms. And the coronavirus epidemic is, unfortunately, alive and well. What are the implications for the gold market? Coronavirus Infects Europe The coronavirus epidemi...
Arkadiusz Sieron | March 2, 2020 |

Bond sell-off is due to become more serious

With my indicators on a sell signal for bonds since August 16, I have been warning about bonds being overbought and in danger of rolling over into a serious correction for several months. And indeed, the 20-year U.S. Treasury bond has already lost 11% of its value just since...
Sy Harding | January 7, 2013 |

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

(TAAT CEO, Setti Coscarella. Image via TAAT Lifestyle & Wellness Ltd.) If you look at one set of market headlines around COVID-19, you would read about stimulus packages, vaccine rollouts, and a general lightening in sentiment … but if you look news outlets, you see...
Stockhouse Editorial | February 10, 2021 |

The Repo Liquidity Crunch Reveals Market Stress. Will Gold Shine?

Last week, the Fed had to inject liquidity into the repo market for the first time since the Great Recession . Not once, but several times – and also commit to do more. Will such a crack in the proverbial dam let gold’s allure shine? Scramble for Liquidity ...
Arkadiusz Sieron | September 24, 2019 |

Gold, the Ultimate Safe Haven Asset. A Looming Nobel Prize?

Yesterday, the Nobel prizes in economics were awarded. Unfortunately, gold has been omitted and got nothing. How unfair! But looking at the Dutch central bank press release, gold would have much higher chances if they were the ones granting the prizes and not the Swedish ...
Arkadiusz Sieron | October 16, 2019 |

Coronavirus, Powell and Gold

The number of cases and deaths by the new coronavirus have escalated quickly. However, the fears subsided and the stock market rebounded. How did gold perform, and what can we expect from the king of metals next? Should We Stop Worrying about the Coronavirus? Well, that...
Arkadiusz Sieron | February 13, 2020 |

Sweden Ends Its Experiment with Negative Interest Rates. Should Gold Be Worried?

Teaser: Sweden has the world’s oldest central bank. The Riksbank has ended its experiment with the negative interest rate policy . That’s a major U-turn. We invite you to read our today’s article, which examines that huge chan...
Arkadiusz Sieron | February 28, 2020 |

Global Pandemic Is On and Stock Bears Roar. Will Gold Make a Move?

On Wednesday, WHO declared the current outbreak of COVID-19 as a global pandemic, while the US stock market entered the bear market as it had fallen over 20% from its peak. What’s next in store for the yellow metal? It’s Global Pandemic Now ...
Arkadiusz Sieron | March 12, 2020 |

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...
Streetwise Reports | March 26, 2020 |

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. Critical care immunotherapy company CytoSorbents Corp....
Streetwise Reports | April 14, 2020 |
1 2 3